| Health / Medical Topics |
Bcl-2 Inhibitor GDC-0199
An orally bioavailable, selective small molecule inhibitor of the anti-apoptotic protein Bcl-2, with potential antineoplastic activity. GDC-0199 mimics BH3-only proteins, the native ligands of Bcl-2 and apoptosis activators, by binding to the hydrophobic groove of Bcl-2 proteins thereby repressing Bcl-2 activity and restoring apoptotic processes in tumor cells. Bcl-2 protein is overexpressed in some cancers and plays an important role in the regulation of apoptosis; its expression is associated with increased drug resistance and tumor cell survival. Compared to the Bcl-2 inhibitor navitoclax, this agent does not inhibit bcl-XL and does not cause bcl-XL-mediated thrombocytopenia. (NCI Thesaurus)
YOU MAY ALSO LIKE
Proteins that are related to bcl-2 are characterized by the presence of one or more highly conserved stretches of homology with bcl-2,…
Bcl-2 homologous antagonist/killer (211 aa, ~23 kDa) is encoded by the human BAK1 gene. This protein is involved in both protein-protein interactions…
The BCL-2 Gene Family encodes proteins that contain Bcl-2 homology (BH) domains (1, 2, 3, or 4), involved in interactions among apoptotic…
A substance being studied in the treatment of cancer. It may kill cancer cells by blocking the production of a protein that…
A purified Keyhole Limpet Hemocyanin, a potent antigenic protein capable of eliciting both humoral and cellular immune responses against tumor cells. …
Human BCHE wild-type allele is located within 3q26.1-q26.2 and is approximately 65 kb in length. This allele, which encodes cholinesterase protein, plays…
